Neovasc Inc. Share Based Compensation of Revenue

Share Based Compensation of Revenue of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Share Based Compensation of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Share Based Compensation of Revenue for the quarter ending March 31, 2022 was 173.39% (a -237.68% decrease compared to previous quarter)
  • Year-over-year quarterly Share Based Compensation of Revenue decreased by -46.91%
  • Annual Share Based Compensation of Revenue for 2021 was 210.19% (a -11.43% decrease from previous year)
  • Annual Share Based Compensation of Revenue for 2020 was 237.31% (a 58.86% increase from previous year)
  • Annual Share Based Compensation of Revenue for 2019 was 149.38% (a -24.38% decrease from previous year)
  • Twelve month Share Based Compensation of Revenue ending March 31, 2022 was 146.55% (a -29.79% decrease compared to previous quarter)
  • Twelve month trailing Share Based Compensation of Revenue decreased by -54.95% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
146.55% 208.73% 333.83% 325.3%
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Share Based Compensation of Revenue of Neovasc Inc.

Most recent Share Based Compensation of Revenueof NVCN including historical data for past 10 years.

Interactive Chart of Share Based Compensation of Revenue of Neovasc Inc.

Neovasc Inc. Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 173.39%
2021 -125.94% 255.56% 326.57% 529.46% 210.19%
2020 277.63% 216.19% 358.84% 200.47% 237.31%
2019 101.86% 146.89% 191.45% 176.87% 149.38%
2018 271.17% 333.67% 37.04% 35.36% 197.54%
2017 33.06% 24.96% 28.64% 91.92% 44.4%
2016 -0.04% 19.12% 39.13% 27.99% 19.03%
2015 184.99% 0.0% 38.45% 51.84% 41.43%
2014 322.84% 0.0% 0.0% 0.0% 59.87%
2013 0.0% 0.0% 0.0% 0.0% 0.0%
2012 0.0% 0.0% 0.0% 0.0% 0.0%
2011 0.0% 0.0%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.